Catamaran acquires Salveo Specialty Pharmacy for $260 million

Download PDF Copy

Jan 5 2015

Catamaran Corp. (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management (PBM) services and technology solutions, announced today the completion, effective as of January 2, 2015, of its previously disclosed acquisition of Salveo Specialty Pharmacy, for a purchase price of $260 million in cash, subject to certain customary post-closing adjustments. The purchase price was funded from Catamaran's existing cash balance.

"This reaffirms our commitment to grow our specialty pharmacy capabilities," said Mark Thierer, Chairman and CEO of Catamaran. "Salveo and BriovaRx™ are highly complementary to each other and the combination presents a great opportunity to further expand our specialty scale."

Salveo Specialty Pharmacy is an independent specialty pharmacy company headquartered in St. Petersburg, Fla., with business operations in New York (Echo Salveo Specialty Pharmacy) and California (Mission Road Pharmacy). Salveo manages approximately $400 million in annual drug spend.

Source:

Catamaran

Posted in: Business / Finance | Healthcare News

Comments (0)

Download PDF Copy

Suggested Reading

Can drones become the frontline of medical delivery in flood-hit regions?

Experts call for coordinated global action to make the most of Alzheimer’s treatments

CHAPPER healthcare, AscellaHealth’s global pharmaceutical distributor, assumes presidency of EUROPACCESS, enhancing access to innovative medicines

AI must optimize home care, continuity, and early detection for older adults

Radiometer featured in the 2025 edition of the Healthcare & Life Sciences Review Denmark

New epimodulation approach improves outbreak forecasts

Giles introduces AI agent to accelerate healthcare and life science research

Aston University and BCHC strengthen partnership with new memorandum of understanding

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.